Product Information

ROWEEPRA 500 MG TABLET is a generic product labeled by OWP Pharmaceuticals, Inc., priced at $0.0735 per EA under NDC 69102010501. Its NADAC has been published 298 times since Mar 10, 2021.

FDA first approved this application on Jan 15, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROWEEPRA 500 MG TABLET

Levetiracetam
$0.0735per EA

Strength

500 mg/1

NDC

69102010501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA078858

FDA Approved

1/15/2009

TE Code

AB

On Market Since

10/28/2020

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for ROWEEPRA 500 MG TABLET has been published 298 times since Mar 10, 2021, and over the history we have for it it has declined 40.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0735 per EA
All-time high$0.1251 (Aug 11, 2021)
All-time low$0.0608 (Nov 20, 2024)
52-week high$0.0780
52-week low$0.0722
Median price$0.0901
Average price$0.0899
Largest weekly change-26.6% (Nov 20, 2024)
Weeks tracked298
Tracking sinceMar 10, 2021

Price History

1W

+1.7%

1M

-0.2%

3M

-0.6%

6M

-5.8%

1Y

-2.4%

3Y

-22.5%

5Y

-33.2%

All

-40.5%

Generic Alternatives

The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ROWEEPRA 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROWEEPRA 500 MG TABLET, manufactured by OWP Pharmaceuticals, Inc., is $0.0735 per EA (NDC 69102010501), effective Nov 18, 2026.

How has the price of ROWEEPRA 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for ROWEEPRA 500 MG TABLET has declined 40.5%. It has been tracked across 298 weekly CMS publications since Mar 10, 2021.

What are the highest and lowest recorded NADAC prices for ROWEEPRA 500 MG TABLET?

Since Mar 10, 2021, the NADAC for ROWEEPRA 500 MG TABLET has ranged from a low of $0.0608 (Nov 20, 2024) to a high of $0.1251 (Aug 11, 2021), with a median of $0.0901 per EA.

Are there cheaper alternatives to ROWEEPRA 500 MG TABLET?

Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 500 MG TABLET, is $0.0720 per EA — about 2% below ROWEEPRA 500 MG TABLET.

Who manufactures ROWEEPRA 500 MG TABLET?

ROWEEPRA 500 MG TABLET (NDC 69102010501) is labeled by OWP Pharmaceuticals, Inc., and CMS classifies it as a generic product.